Does gSK-3β inhibition promote early engraftment of ex vivo-expanded haematopoietic stem cells?
Pharmacological inhibition of GSK-3β provided a novel approach to improve early engraftment of ex vivo-expanded haematopoietic progenitor cells.
In this population, a combined multimodal CT score predicted futile recanalization.